Liquid Biopsy Market Production Analysis, Revenue, Advancement Strategy and Geographical Market Performance Forecast To 2030


Posted July 8, 2021 by ramacharitbrc

Major players in the liquid biopsy market are QIAGEN N.V., Roche Diagnostics, Bio-Rad Laboratories Inc., Myriad Genetics, Inc., Guardant Health Inc., Thermo Fisher Scientific, Guardant Health.... @ @ https://bit.ly/3qTxZfD
 
Liquid Biopsy Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact – both negative and positive – of COVID-19 on the liquid biopsy industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. This includes revised market numbers according to the effects of the coronavirus and the expected liquid biopsy market growth numbers 2021-2030.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-market-global-report

The Liquid Biopsy Global Market Report 2021-30 by The Business Research Company provides an in-depth analysis of the global liquid biopsy market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030. The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Liquid Biopsy Global Market Report 2021 covers liquid biopsy market drivers, liquid biopsy market trends, liquid biopsy market growth rate, liquid biopsy market major players, player-adopted strategies in the market, and liquid biopsy market size.

The global liquid biopsy market is expected to grow from $3.4 billion in 2020 to $3.87 billion in 2021 at a compound annual growth rate (CAGR) of 13.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The liquid biopsy market is expected to reach $7.57 billion in 2025 at a CAGR of 18%.

Request For The Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

The report covers the liquid biopsy market segments-
1) By Product: Assays Kits, Instruments, Services
2) By End User: Reference Laboratories, Hospitals And Physician Laboratories, Academic And Research Centers
3) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics

About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By TBRC
Country United States
Categories Advertising , Health
Last Updated July 8, 2021